Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 47Neoplasm Metastasis 9Neoplasms 8Prostatic Neoplasms 7Brain Neoplasms 7Endometrial Neoplasms 6Glioblastoma 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Meningioma 3Carcinoma, Renal Cell 3Sarcoma 2Recurrence 2Pancreatic Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Liposarcoma 2Hematologic Neoplasms 2Glioma 2Breast Neoplasms, Male 2Breast Diseases 2Breast Cancer Female 2Venous Thromboembolism 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1

Interventions

pembrolizumab 3lenvatinib 3gallium 68 PSMA-11 2apatinib 2Protons 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Epirubicin 2Cisplatin 2Carboplatin 2Axitinib 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2tislelizumab 1regorafenib 1enfortumab vedotin 1cabozantinib 1avelumab 1anlotinib 1amivantamab 1abemaciclib 1Tretinoin 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Adenoid Cystic × abemaciclib × Clear all
NCT05774899 2025-06-17

CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

Dana-Farber Cancer Institute

Phase 1/2 Recruiting
32 enrolled

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡